| 000 | 01885 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516025256.0 | ||
| 264 | 0 | _c20120502 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1437-7780 | ||
| 024 | 7 |
_a10.1007/s10156-011-0222-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShirasaka, Takuma | |
| 245 | 0 | 0 |
_aInvestigation of emtricitabine-associated skin pigmentation and safety in HIV-1-infected Japanese patients. _h[electronic resource] |
| 260 |
_bJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy _cOct 2011 |
||
| 300 |
_a602-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 |
_aDeoxycytidine _xadverse effects |
| 650 | 0 | 4 | _aDermoscopy |
| 650 | 0 | 4 | _aEmtricitabine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHand |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 |
_aLentigo _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPigmentation Disorders _xchemically induced |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 650 | 0 | 4 |
_aSkin Pigmentation _xdrug effects |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aTadokoro, Taketsugu | |
| 700 | 1 | _aYamamoto, Yasuyuki | |
| 700 | 1 | _aFukutake, Katsuyuki | |
| 700 | 1 | _aKato, Yukihiko | |
| 700 | 1 | _aOdawara, Takashi | |
| 700 | 1 | _aNakamura, Tetsuya | |
| 700 | 1 | _aAjisawa, Atsushi | |
| 700 | 1 | _aNegishi, Masayoshi | |
| 773 | 0 |
_tJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy _gvol. 17 _gno. 5 _gp. 602-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10156-011-0222-5 _zAvailable from publisher's website |
| 999 |
_c20642813 _d20642813 |
||